Can acute lymphoblastic leukemia be cured

Some patients with acute lymphoblastic leukemia can achieve clinical cure through standardized treatment. The therapeutic effect is closely related to factors such as age, classification, and gene mutations, and the cure rate in children is significantly higher than that in adults. The cure rate of acute lymphoblastic leukemia in children can reach over 80%. Children with high sensitivity to chemotherapy drugs can achieve long-term disease-free survival by combining strong chemotherapy such as VDLD regimen with central nervous system prophylaxis. During the treatment process, it is necessary to closely monitor small residual lesions and adjust the treatment plan in a timely manner. Standardizing the completion of 2-3 years of maintenance treatment is the key to preventing recurrence. The cure rate for adult patients is about 40-50%. High risk patients should consider allogeneic hematopoietic stem cell transplantation, and the five-year survival rate after transplantation can reach 60%. Elderly patients or those with underlying diseases have poor treatment tolerance and often use reduced intensity chemotherapy regimens. The application of targeted drugs such as tyrosine kinase inhibitors significantly improves the prognosis of Ph positive patients.

It is recommended to seek medical attention at a specialized hematology hospital immediately after diagnosis, pay attention to preventing infection during treatment, and maintain a balanced diet. Regularly review blood routine and bone marrow puncture, strictly follow medical advice to complete the entire treatment process. Long term follow-up is still necessary after recovery to monitor long-term complications.